Phathom Pharmaceuticals, Inc. (PHAT) has a market capitalization of $998.38M and trades at $12.67. The 52-week range is 2.21-18.31.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -4.2, Earnings Per Share (EPS) of $-3.03, annual revenue of $175.11M.
The stock has a beta of 0.61, operates in the Healthcare sector.
